Profile

Robert J. Stratta, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

33 Ratings
11 Comments
 

Robert J. Stratta, M.D.

Professor, Surgical Sciences-Transplant



Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Organ Preservation and Procurement, Transplant Immunosuppression, General Surgery, Transplant Surgery

Contact Information

Returning Patient Appointments: 336-716-0548
Department: 336-716-0548

Email: rstratta@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., University of Notre Dame, 1976
  • M.D., University of Chicago, 1980
  • Internship, University of Utah, 1981
  • Residency, University of Utah College of, 1986
  • Fellowship, University of Wisconsin-Madiso, 1988

Board Certifications

  • American Board of Surgery, Surgery

NPI Number

  • 1346226966
Robert J. Stratta, M.D.

Doctor Rating

4.8 out of 5

33 Ratings
11 Comments
 

Robert J. Stratta, M.D.

Professor, Surgical Sciences-Transplant
Center on Diabetes, Obesity, and Metabolism
Institute for Regenerative Medicine
Urology

Research Interests

Pancreas Transplantation; Kidney Transplantation; Graft Rejection; Immunosuppressive Agents; Tissue Donors
More »

Contact Information

Department: 336-716-0548

Email: rstratta@wakehealth.edu

Media Medical Expert »

Recent Publications

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.. Expert Rev Clin Immunol. 2016;12(2):169-182.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.. Ann Surg. 2016;264(1):169-179.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):43.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):44.

Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R.. Am J Transplant. 2016;16(Suppl 1):53.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.. Clin Transplant. 2016;30(4):380-392.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Pancreas transplantation: a decade of decline. Stratta RJ, Fridell JA, Gruessner AC, Odorico JS, Gruessner RW.. Curr Opin Organ Transplant. 2016;21(4):386-392.

Pancreas transplantation: an alarming crisis in confidence. Stratta RJ, Gruessner AC, Odorico JS, Fridell JA, Gruessner RW.. Am J Transplant. 2016;16(9):2556-2562.

The future of pancreas transplantation: 'ain't what it used to be' [editorial]. Stratta RJ.. Curr Opin Organ Transplant. 2016;21(4):375-376.

Exocrine drainage in vascularized pancreas transplantation in the new millennium. El-Hennawy H, Stratta RJ, Smith F.. World J Transplant. 2016;6(2):255-271.

Successful ABO-incompatible renal transplantation: blood group A1B donor into A2B recipient with anti-A1 isoagglutinins. Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ.. Am J Clin Pathol. 2016;146(2):268-271.

Single-center experience with deceased donor kidney transplantation in 114 individuals aged 70 and older in the new millennium [letter]. Stratta RJ, Farney AC, Palanisamy A, Rogers J, Orlando G, Reeves-Daniel A.. J Am Geriatr Soc. 2016;64(11):e219-e221.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.. J Nephrol. 2015;28(3):379-385.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Farney AC, Rogers J, Orlando G, Stratta RJ.. Curr Opin Organ Transplant. 2015;20(1):103-107.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Prospect for kidney bioengineering: shortcomings of the status quo. Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.. Expert Opin Biol Ther. 2015;15(4):547-558.

Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G.. Am J Transplant. 2015;15(Suppl 1):49.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand. Salvatori M, Peloso A, Katari R, Soker S, Lerut JP, Stratta RJ, Orlando G.. Xenotransplantation. 2015;22(1):1-6.

The search for the optimal antibody induction strategy in kidney transplantation: still 'hazy' after all these years [commentary]. Stratta RJ.. Clin Transplant. 2015;29(7):569-572.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

Renal extracellular matrix scaffolds from discarded kidneys maintain glomerular morphometry and vascular resilience and retains critical growth factors. Peloso A, Petrosyan A, Da Sacco S, Booth C, Zambon JP, O'Brien T, Aardema C, Robertson J, De Filippo RE, Soker S, Stratta RJ, Perin L, Orlando G.. Transplantation. 2015;99(9):1807-1816.

Renal ECM scaffolds from discarded kidneys are bioactive, pro-tolerogenic, cyto-compatible and feature an intact, patent and resilient vascular feature an intact, patent and resilient vasculature [abstract]. Orlando G, Pelso A, Petrosyan A, Da Sacco S, Cravedi P, Zambon J, Soker S, DeFilippo RE, Stratta R, Perin L.. Tissue Eng Part A. 2015;21(Suppl 1):S103-S104.

The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Orlando G, Urbani L, Cravedi P, Sordi V, Guoguang N, Citro A, Mcquilling J, Farney A, Iskandar S, Rogers J, Stratta R, Opara E, Piemonti L, Soker S, De Coppi P, Petrosyan A.. Tissue Eng Part A. 2015;21(Suppl 1):S141.

Can post-transplant C-peptide be used as an indicator of pancreas graft failure? [abstract]. Carrico R, Fridell J, Odorico J, Stratta R, Tyler K, Niederhaus S, Kandaswamy R, Fisher J, Olaitan O, Mujtaba M.. Xenotransplantation. 2015;22(Suppl 1):S2-S3.

Can post-transplant C-peptide be used as an indicator of pancreas graft failure? [abstract]. Carrico R, Fridell J, Odorico J, Stratta R, Tyler K, Niederhaus S, Kandaswamy R, Fisher J, Olaitan O, Mujtaba M.. Transplantation. 2015;99(11 Suppl 2):S3.

Renal ECM scaffolds from discarded kidneys are bioactive, pro-tolerogenic, cyto-compatible and feature an intact, patient and resilient vascular feature an intact, patent and resilient vasculature [abstract]. Orlando G, Peloso A, Petrosyan A, Da Sacco S, Cravedi P, Zambon JP, O'Brien T, Aardema C, Robertson J, De Filippo RE, Soker S, Stratta RJ, Laura P.. Transpl Int. 2015;28(Suppl 4):15-16.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new generation bioartificial endocrine pancreas [abstract]. Orlando G, Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas EMA, Sordi V, Purroy C, Niu GG, Mcquilling JP, Sivanandane S, Farney AC, Iskandar SS, Rogers J, Stratta RJ, Opara EC, Piemonti L, Soker S, De Coppi P.. Transpl Int. 2015;28(Suppl 4):129.

Analysis of patient refusals for transplantation [abstract]. Reeves-Daniel A, Palanisamy A, Orlando G, Rogers J, Russell G, Farney A, Burkart J, Stratta R, Freedman B.. Am J Transplant. 2015;15(Suppl 3):1761.

Import pancreas transplants: good from far or far from good? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R.. Am J Transplant. 2015;15(Suppl 3):1068.

Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ.. Clin Transplant. 2014;28(1):16-26.

Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74-75.

Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Stratta RJ, Farney AC, Rogers J, Orlando G.. Expert Rev Clin Immunol. 2014;10(1):117-132.

Influence of prolonged cold ischemia in the era of marginal donor utilization [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Successful unintentional ABO-incompatible renal transplantation: blood group A1B donor into an A2B recipient. Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ.. Am J Clin Pathol. 2014;141(5):724-726.

Will regenerative medicine replace transplantation?. Orlando G, Soker S, Stratta RJ, Atala A. In: Turka LA, Wood KJ, eds. Transplantation. New York: Cold Spring Harbor Laboratory Press;2014: 407-420.

Renal bioengineering with scaffolds generated from human kidneys. Katari R, Peloso A, Zambon JP, Soker S, Stratta RJ, Atala A, Orlando G.. Nephron Exp Nephrol. 2014;126(2):119.

Cell replacement strategies aimed at reconstitution of the beta-cell compartment in type 1 diabetes. Orlando G, Gianello P, Salvatori M, Stratta RJ, Soker S, Ricordi C, Dominguez-Bendala J.. Diabetes. 2014;63(5):1433-1444.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):855.

Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Sciences-Transplant

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Organ Preservation and Procurement, Transplant Immunosuppression, General Surgery, Transplant Surgery
Robert J. Stratta, M.D.

Robert J. Stratta, M.D.

Professor, Surgical Sciences-Transplant
Center on Diabetes, Obesity, and Metabolism
Institute for Regenerative Medicine
Urology

Doctor Rating

4.8 out of 5

Robert J. Stratta, M.D.33 Ratings
11 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
5.0
CP explanations of prob/condition
4.9
CP spoke using clear language
5.0
Friendliness/courtesy of CP
5.0
Likelihood of recommending CP
5.0
Patients' confidence in CP
5.0
Time CP spent with patient
4.9
Wait time at clinic
4.0



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

10/24/2016

I think the entire staff is great and the best I have ever visited. Great doctors and nurses. #10. I will.

10/18/2016

*Dr. Stratta is the best!!

9/20/2016

The Dr.'s are great. Take the time to answer all my questions or concerns.

8/23/2016

Knowledgeable, professional and caring. *Dr. Stratta is a pleasure to work with. I always enjoy seeing him.

8/19/2016

*Dr. Stratta is brilliant. He is an outstanding physician. He explains in detail. He covers all aspects of care. We are blessed to have him & WFBH is also.

7/23/2016

The dr. really seems concerned & cares about how I feel & what going on with me.

4/28/2016

*Dr. Stratta is an excellent care provider. He's passionate about what he does and it shows. I feel very fortunate to have him as my doctor.

4/28/2016

*Dr. Stratta is a very personable, caring professional.

3/9/2016

Everything was explained and even showed to me what I needed to do and how to do it.

2/16/2016

1st meeting of *Dr. Stratta. Was very impressed.

1/26/2016

Knowledgeable & caring, *Dr. Stratta is one of the best doctors I have ever had.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.